Cargando…
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
The aim of our study is to investigate patient selection for the 21-gene recurrence score assay (RS) for breast cancer (BC) and the RS impact on chemotherapy administration (Chemo) in clinical practice across the United States through the retrospective observational study of National Cancer Data Bas...
Autores principales: | Orucevic, Amila, Heidel, Robert E., Bell, John L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903105/ https://www.ncbi.nlm.nih.gov/pubmed/27206678 http://dx.doi.org/10.1007/s10549-016-3833-9 |
Ejemplares similares
-
Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data
por: Orucevic, Amila, et al.
Publicado: (2017) -
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
por: Qi, Peng, et al.
Publicado: (2021) -
Breast Cancer in Elderly Caucasian Women—An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival
por: Orucevic, Amila, et al.
Publicado: (2015) -
Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors
por: Ankersmid, J. W., et al.
Publicado: (2022) -
Recurrent read-through fusion transcripts in breast cancer
por: Varley, Katherine E., et al.
Publicado: (2014)